| Title : Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine* - Nieoullon_2008_Curr.Med.Res.Opin_24_3357 |
| Author(s) : Nieoullon A , Bentue-Ferrer D , Bordet R , Tsolaki M , Forstl H |
| Ref : Curr Med Res Opin , 24 :3357 , 2008 |
| Abstract : |
| PubMedSearch : Nieoullon_2008_Curr.Med.Res.Opin_24_3357 |
| PubMedID: 19032118 |
| Title : Treatment of the mild cognitive impairment (MCI) - Allain_2007_Hum.Psychopharmacol_22_189 |
| Author(s) : Allain H , Bentue-Ferrer D , Akwa Y |
| Ref : Hum Psychopharmacol , 22 :189 , 2007 |
| Abstract : |
| PubMedSearch : Allain_2007_Hum.Psychopharmacol_22_189 |
| PubMedID: 17415706 |
| Title : [Pharmacology of Alzheimer's disease: where do we go from here?] - Sellal_2005_Therapie_60_89 |
| Author(s) : Sellal F , Nieoullon A , Michel G , Michel BF , Lacomblez L , Geerts H , Delini-Stula A , Bentue-Ferrer D , Bordet R , Allain H |
| Ref : Therapie , 60 :89 , 2005 |
| Abstract : |
| PubMedSearch : Sellal_2005_Therapie_60_89 |
| PubMedID: 15969312 |
| Title : [Pharmacological treatment in severe dementia] - Jouanny_2005_Psychol.Neuropsychiatr.Vieil_3 Suppl 1_S51 |
| Author(s) : Jouanny P , Belliard S , Bentue-Ferrer D , Michel O , Allain H |
| Ref : Psychol Neuropsychiatr Vieil , 3 Suppl 1 :S51 , 2005 |
| Abstract : |
| PubMedSearch : Jouanny_2005_Psychol.Neuropsychiatr.Vieil_3 Suppl 1_S51 |
| PubMedID: 15899605 |
| Title : Mild cognitive impairment: a treatment at last? - |
| Author(s) : Allain H , Bentue-Ferrer D , Akwa Y |
| Ref : Lancet Neurol , 3 :643 , 2004 |
| PubMedID: 15488455 |
| Title : [Biology of motivation] - Allain_2004_Psychol.Neuropsychiatr.Vieil_2_167 |
| Author(s) : Allain H , Bentue-Ferrer D , Lacomblez L |
| Ref : Psychol Neuropsychiatr Vieil , 2 :167 , 2004 |
| Abstract : |
| PubMedSearch : Allain_2004_Psychol.Neuropsychiatr.Vieil_2_167 |
| PubMedID: 15689330 |
| Title : [What is dementia? 5. Anti-dementia drug: myth or reality?] - Allain_2003_Psychol.Neuropsychiatr.Vieil_1_151 |
| Author(s) : Allain H , Bentue-Ferrer D |
| Ref : Psychol Neuropsychiatr Vieil , 1 :151 , 2003 |
| Abstract : |
| PubMedSearch : Allain_2003_Psychol.Neuropsychiatr.Vieil_1_151 |
| PubMedID: 15683950 |
| Title : Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists - Bentue-Ferrer_2003_CNS.Drugs_17_947 |
| Author(s) : Bentue-Ferrer D , Tribut O , Polard E , Allain H |
| Ref : CNS Drugs , 17 :947 , 2003 |
| Abstract : |
| PubMedSearch : Bentue-Ferrer_2003_CNS.Drugs_17_947 |
| PubMedID: 14533945 |
| Title : Drugs and vascular dementia - Allain_2003_Dement.Geriatr.Cogn.Disord_16_1 |
| Author(s) : Allain H , Bentue-Ferrer D , Tribut O , Pinel JF |
| Ref : Dementia & Geriatric Cognitive Disorders , 16 :1 , 2003 |
| Abstract : |
| PubMedSearch : Allain_2003_Dement.Geriatr.Cogn.Disord_16_1 |
| PubMedID: 12714793 |
| Title : Alzheimer's disease: the pharmacological pathway - Allain_2003_Fundam.Clin.Pharmacol_17_419 |
| Author(s) : Allain H , Bentue-Ferrer D , Tribut O , Gauthier S , Michel BF , Drieu-La Rochelle C |
| Ref : Fundamental & Clinical Toxicology , 17 :419 , 2003 |
| Abstract : |
| PubMedSearch : Allain_2003_Fundam.Clin.Pharmacol_17_419 |
| PubMedID: 12914543 |
| Title : [Adverse effects and drugs for Alzheimer's disease] - Schuck_1999_Therapie_54_237 |
| Author(s) : Schuck S , Bentue-Ferrer D , Beaufils C , Polard E , Belliard S , Allain H |
| Ref : Therapie , 54 :237 , 1999 |
| Abstract : |
| PubMedSearch : Schuck_1999_Therapie_54_237 |
| PubMedID: 10394260 |
| Title : Drugs used in Alzheimer's disease and neuroplasticity - Allain_1997_Clin.Ther_19_4 |
| Author(s) : Allain H , Bentue-Ferrer D , Gandon JM , Le Doze F , Belliard S |
| Ref : Clin Ther , 19 :4 , 1997 |
| Abstract : |
| PubMedSearch : Allain_1997_Clin.Ther_19_4 |
| PubMedID: 9083704 |